Last reviewed · How we verify
Anti-adhesion barrier gel
At a glance
| Generic name | Anti-adhesion barrier gel |
|---|---|
| Also known as | AAB |
| Sponsor | Nadezhda Women's Health Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy (NA)
- Hysteroscopy vs. Endouterine Aspiration in the Management of Trophoblastic Retention (NA)
- The Assessment of the Use of Anti-Adhesion Agents to Prevent Pelvic Postoperative Adhesions (NA)
- Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-adhesion barrier gel CI brief — competitive landscape report
- Anti-adhesion barrier gel updates RSS · CI watch RSS
- Nadezhda Women's Health Hospital portfolio CI